Chemokine Receptors in T-Cell-Mediated Diseases of the Skin

被引:30
|
作者
Lonsdorf, Anke S. [1 ]
Hwang, Sam T. [2 ]
Enk, Alexander H. [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Dermatol, D-69115 Heidelberg, Germany
[2] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA
关键词
MACROPHAGE INFLAMMATORY PROTEIN-3-ALPHA/CCL20; ACTIVATION-REGULATED CHEMOKINE; CUTANEOUS LYMPHOCYTE ANTIGEN; ELEVATED SERUM CTACK/CCL27; ATOPIC-DERMATITIS; MYCOSIS-FUNGOIDES; CUTTING EDGE; DENDRITIC CELLS; EPIDERMAL HYPERPLASIA; IMMUNE SURVEILLANCE;
D O I
10.1038/jid.2009.122
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The chemokine/chemokine receptor network is an integral element of the complex system of homeostasis and immunosurveillance. Initially studied because of their role in coordinating tissue-specific migration and activation of leucocytes, chemokines have been implicated in the pathogenesis of various malignancies and diseases with strong inflammatory components. We discuss recent findings suggesting a critical involvement of chemokine receptor interactions in the immunopathogenesis of classical inflammatory skin disorders such as psoriasis and atopic dermatitis, as well as neoplastic diseases with a T-cell origin, such as mycosis fungoides. A deeper understanding of the underlying contribution of the chemokine network in the disease processes is key for the development of selective targeted immunotherapeutics that may meet the delicate balance between efficacy and safety.
引用
收藏
页码:2552 / 2566
页数:15
相关论文
共 50 条
  • [1] Animal models of T-cell-mediated skin diseases
    Zollner, TM
    Renz, H
    Igney, FH
    Asadullah, K
    BIOESSAYS, 2004, 26 (06) : 693 - 696
  • [2] Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T-cell-mediated skin diseases
    Ferran, Marta
    Romeu, Ester R.
    Rincon, Catalina
    Sagrista, Marc
    Gimenez Arnau, Ana M.
    Celada, Antonio
    Pujol, Ramon M.
    Hollo, Peter
    Jokai, Hajnalka
    Santamaria-Babi, Luis F.
    EXPERIMENTAL DERMATOLOGY, 2013, 22 (07) : 439 - 442
  • [3] THE IMMUNOPATHOGENESIS AND REGULATION OF T-CELL-MEDIATED DEMYELINATING DISEASES
    MILLER, SD
    KARPUS, WJ
    IMMUNOLOGY TODAY, 1994, 15 (08): : 356 - 361
  • [4] T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases
    Gonzalez, Hugo
    Pacheco, Rodrigo
    JOURNAL OF NEUROINFLAMMATION, 2014, 11
  • [5] Systemic antigen in the treatment of T-cell-mediated autoimmune diseases
    Liblau, R
    Tisch, R
    Bercovici, N
    McDevitt, HO
    IMMUNOLOGY TODAY, 1997, 18 (12): : 599 - 604
  • [6] T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases
    Hugo González
    Rodrigo Pacheco
    Journal of Neuroinflammation, 11
  • [7] PKCθ:: A potential therapeutic target for T-cell-mediated diseases
    Chaudhary, D
    Kasaian, M
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (05) : 432 - 437
  • [8] In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseases
    M. Alaibac
    A. Belloni Fortina
    A. Poletti
    P. Vandenberghe
    F. Marino
    M. Tarantello
    A. Peserico
    Archives of Dermatological Research, 2000, 292 : 472 - 474
  • [9] In situ expression of the CTLA-4 receptor in T-cell-mediated inflammatory and neoplastic skin diseases
    Alaibac, M
    Fortina, AB
    Poletti, A
    Vandenberghe, P
    Marino, F
    Tarantello, M
    Peserico, A
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2000, 292 (09) : 472 - 474
  • [10] T-cell-mediated autoimmunity - Novel techniques to characterize autoreactive T-cell receptors
    Dornmair, K
    Goebels, N
    Weltzien, HU
    Wekerle, H
    Hohlfeld, R
    AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04): : 1215 - 1226